摘要 |
The present invention relates to compounds of formula (I), wherein R4, R5, R6, R7, Q, m and n are as defined in the specification. The compounds are useful as p38 kinase inhibitors, and therefore, may be used for treatment of p38-mediated disorder. |
申请人 |
F. HOFFMANN-LA ROCHE AG;DUNN, JAMES, PATRICK;GOLDSTEIN, DAVID, MICHAEL;STAHL, CHRISTOPH, MARTIN;TREJO-MARTIN, TERESA ALEJANDRA |
发明人 |
DUNN, JAMES, PATRICK;GOLDSTEIN, DAVID, MICHAEL;STAHL, CHRISTOPH, MARTIN;TREJO-MARTIN, TERESA ALEJANDRA |